These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19324051)

  • 21. Antibody binding site mapping of SARS-CoV spike protein receptor-binding domain by a combination of yeast surface display and phage peptide library screening.
    Zhang X; Wang J; Wen K; Mou Z; Zou L; Che X; Ni B; Wu Y
    Viral Immunol; 2009 Dec; 22(6):407-15. PubMed ID: 19951177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.
    He Y; Li J; Li W; Lustigman S; Farzan M; Jiang S
    J Immunol; 2006 May; 176(10):6085-92. PubMed ID: 16670317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
    van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J
    J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.
    Zhou T; Wang H; Luo D; Rowe T; Wang Z; Hogan RJ; Qiu S; Bunzel RJ; Huang G; Mishra V; Voss TG; Kimberly R; Luo M
    J Virol; 2004 Jul; 78(13):7217-26. PubMed ID: 15194798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
    Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
    J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
    Zhang H; Wang G; Li J; Nie Y; Shi X; Lian G; Wang W; Yin X; Zhao Y; Qu X; Ding M; Deng H
    J Virol; 2004 Jul; 78(13):6938-45. PubMed ID: 15194770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model.
    Du L; Zhao G; He Y; Guo Y; Zheng BJ; Jiang S; Zhou Y
    Vaccine; 2007 Apr; 25(15):2832-8. PubMed ID: 17092615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.
    Yi C; Sun X; Ye J; Ding L; Liu M; Yang Z; Lu X; Zhang Y; Ma L; Gu W; Qu A; Xu J; Shi Z; Ling Z; Sun B
    Cell Mol Immunol; 2020 Jun; 17(6):621-630. PubMed ID: 32415260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.
    Zhao J; Wang W; Yuan Z; Jia R; Zhao Z; Xu X; Lv P; Zhang Y; Jiang C; Gao XM
    Virology; 2007 Mar; 359(2):362-70. PubMed ID: 17055551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention.
    Yeung KS; Yamanaka GA; Meanwell NA
    Med Res Rev; 2006 Jul; 26(4):414-33. PubMed ID: 16521129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization.
    Chakraborti S; Prabakaran P; Xiao X; Dimitrov DS
    Virol J; 2005 Aug; 2():73. PubMed ID: 16122388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor.
    Wu K; Li W; Peng G; Li F
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19970-4. PubMed ID: 19901337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The spike protein of SARS-CoV--a target for vaccine and therapeutic development.
    Du L; He Y; Zhou Y; Liu S; Zheng BJ; Jiang S
    Nat Rev Microbiol; 2009 Mar; 7(3):226-36. PubMed ID: 19198616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.
    Tripet B; Kao DJ; Jeffers SA; Holmes KV; Hodges RS
    J Struct Biol; 2006 Aug; 155(2):176-94. PubMed ID: 16697221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibody.
    Bian C; Zhang X; Cai X; Zhang L; Chen Z; Zha Y; Xu Y; Xu K; Lu W; Yan L; Yuan J; Feng J; Hao P; Wang Q; Zhao G; Liu G; Zhu X; Shen H; Zheng B; Shen B; Sun B
    Virology; 2009 Jan; 383(1):39-46. PubMed ID: 18986662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights from the association of SARS-CoV S-protein with its receptor, ACE2.
    Li W; Choe H; Farzan M
    Adv Exp Med Biol; 2006; 581():209-18. PubMed ID: 17037532
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants.
    Sui J; Li W; Roberts A; Matthews LJ; Murakami A; Vogel L; Wong SK; Subbarao K; Farzan M; Marasco WA
    J Virol; 2005 May; 79(10):5900-6. PubMed ID: 15857975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.
    Lan J; Ge J; Yu J; Shan S; Zhou H; Fan S; Zhang Q; Shi X; Wang Q; Zhang L; Wang X
    Nature; 2020 May; 581(7807):215-220. PubMed ID: 32225176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody.
    Lv Z; Deng YQ; Ye Q; Cao L; Sun CY; Fan C; Huang W; Sun S; Sun Y; Zhu L; Chen Q; Wang N; Nie J; Cui Z; Zhu D; Shaw N; Li XF; Li Q; Xie L; Wang Y; Rao Z; Qin CF; Wang X
    Science; 2020 Sep; 369(6510):1505-1509. PubMed ID: 32703908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction.
    Lin HX; Feng Y; Wong G; Wang L; Li B; Zhao X; Li Y; Smaill F; Zhang C
    J Gen Virol; 2008 Apr; 89(Pt 4):1015-1024. PubMed ID: 18343844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.